Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Smith

Showing results (471-480 of 545) with videos related to

Pageof 55
Sort By:
Journal of Medical Engineering & Technology|July 1, 1985
A versatile speech output communication aidA L Evans, R A Gowdie, D Keating, et al.
Neuroscience Letters|July 17, 1990
Intraventricular infusions of antibodies to amyloid-beta-protein precursor impair the acquisition of a passive avoidance response in the ratE Doyle, M T Bruce, K C Breen, et al.
Toxicon : Official Journal of the International Society on Toxinology|January 1, 1997
Assessment of an ovine antivenom raised against venom from the desert black cobra (Walterinnesia aegyptia)A K al-Asmari, I H al-Abdulla, R G Crouch, et al.
Oncology|October 1, 1994
Cyclic sequential endocrine therapy for advanced breast cancer using a combination of tamoxifen and megestrol acetateD J Crawford, W D George, D C Smith, et al.
Urologic Oncology|January 13, 2011
Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancerJ L Osborn, G G Schwartz, D C Smith, et al.
British Journal of Cancer|January 1, 1981
Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stabilityR E Leake, L Laing, K C Calman, et al.
Cancer Research|October 1, 1976
Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapyA Krishan, S W Pitman, H N Tattersall, et al.
Urology|August 11, 1998
A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancerD C Smith, B G Redman, L E Flaherty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozoleQ Zeng, D C Smith, T J Suscovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancyD C Smith, C S Johnson, C C Freeman, et al.
Pageof 55

Showing results (471-480 of 545) with videos related to

Sort By:
Pageof 55
Journal of Medical Engineering & Technology|July 1, 1985
A versatile speech output communication aidA L Evans, R A Gowdie, D Keating, et al.
Neuroscience Letters|July 17, 1990
Intraventricular infusions of antibodies to amyloid-beta-protein precursor impair the acquisition of a passive avoidance response in the ratE Doyle, M T Bruce, K C Breen, et al.
Toxicon : Official Journal of the International Society on Toxinology|January 1, 1997
Assessment of an ovine antivenom raised against venom from the desert black cobra (Walterinnesia aegyptia)A K al-Asmari, I H al-Abdulla, R G Crouch, et al.
Oncology|October 1, 1994
Cyclic sequential endocrine therapy for advanced breast cancer using a combination of tamoxifen and megestrol acetateD J Crawford, W D George, D C Smith, et al.
Urologic Oncology|January 13, 2011
Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancerJ L Osborn, G G Schwartz, D C Smith, et al.
British Journal of Cancer|January 1, 1981
Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stabilityR E Leake, L Laing, K C Calman, et al.
Cancer Research|October 1, 1976
Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapyA Krishan, S W Pitman, H N Tattersall, et al.
Urology|August 11, 1998
A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancerD C Smith, B G Redman, L E Flaherty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozoleQ Zeng, D C Smith, T J Suscovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancyD C Smith, C S Johnson, C C Freeman, et al.
Pageof 55